FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2134913151> ?p ?o ?g. }

• W2134913151 endingPage "38" @default.
• W2134913151 startingPage "25" @default.
• W2134913151 abstract "Parkinson's disease (PD) is characterized by progressive loss of dopaminergic (DA) neurons in the substantia nigra. However, studies of post-mortem PD brains have shown that not only DA neurons but also the noradrenergic (NA) neurons in the locus coeruleus degenerate, and that the NA neurodegeneration may be as profound, and also precede degeneration of the midbrain DA neurons. Previous studies in animal models of PD have suggested that loss of forebrain NA will add to the development of motor symptoms in animals with lesions of the nigrostriatal DA neurons, but the results obtained in rodents have been inconclusive due to the shortcomings of the toxin, DSP-4, used to lesion the NA projections. Here, we have developed an alternative double-lesion paradigm using injections of 6-OHDA into striatum in combination with intraventricular injections of a powerful NA immunotoxin, anti-DBH-Saporin, to eliminate the NA neurons in the locus coeruleus, and associated pontine nuclei. Animals with combined DA and NA lesions were more prone to develop L-DOPA-induced dyskinesia, even at low L-DOPA doses, and they performed significantly worse in tests of reflexive and skilled paw use, the stepping and staircase tests, compared to DA-only lesioned rats. Post-mortem analysis revealed that NA depletion did not affect the degree of DA depletion, or the loss of tyrosine hydroxylase-positive innervation in the striatum. Cell loss in the substantia nigra was similar in both single and double lesioned animals, showing that the worsening effect was not due to increased loss of nigral DA neurons. The results show that damage to brainstem NA neurons, contributes to the development of motor impairments and the appearance of L-DOPA-induced dyskinesia in 6-OHDA lesioned rats, and provide support for the view that the development of motor symptoms and dyskinetic side effects in PD patients reflects the combined loss of midbrain DA neurons and NA neurons." @default.
• W2134913151 created "2016-06-24" @default.
• W2134913151 creator A5011110065 @default.
• W2134913151 creator A5030271784 @default.
• W2134913151 creator A5034813656 @default.
• W2134913151 creator A5047762447 @default.
• W2134913151 creator A5082558832 @default.
• W2134913151 date "2014-07-01" @default.
• W2134913151 modified "2023-09-27" @default.
• W2134913151 title "Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease" @default.
• W2134913151 cites W1543478231 @default.
• W2134913151 cites W1602500762 @default.
• W2134913151 cites W1966260988 @default.
• W2134913151 cites W1970800428 @default.
• W2134913151 cites W1974703596 @default.
• W2134913151 cites W1975040149 @default.
• W2134913151 cites W1975655223 @default.
• W2134913151 cites W1977307368 @default.
• W2134913151 cites W1980275914 @default.
• W2134913151 cites W1989750506 @default.
• W2134913151 cites W1993986783 @default.
• W2134913151 cites W1997008008 @default.
• W2134913151 cites W1999585129 @default.
• W2134913151 cites W2008244365 @default.
• W2134913151 cites W2010680364 @default.
• W2134913151 cites W2012464232 @default.
• W2134913151 cites W2018524068 @default.
• W2134913151 cites W2019452853 @default.
• W2134913151 cites W2023026189 @default.
• W2134913151 cites W2023325653 @default.
• W2134913151 cites W2035266273 @default.
• W2134913151 cites W2039449904 @default.
• W2134913151 cites W2043115981 @default.
• W2134913151 cites W2043222662 @default.
• W2134913151 cites W2044801311 @default.
• W2134913151 cites W2047691623 @default.
• W2134913151 cites W2052875613 @default.
• W2134913151 cites W2054684288 @default.
• W2134913151 cites W2055760464 @default.
• W2134913151 cites W2059449602 @default.
• W2134913151 cites W2060097603 @default.
• W2134913151 cites W2061515934 @default.
• W2134913151 cites W2061978580 @default.
• W2134913151 cites W2065590805 @default.
• W2134913151 cites W2065723600 @default.
• W2134913151 cites W2066113689 @default.
• W2134913151 cites W2066687408 @default.
• W2134913151 cites W2070821230 @default.
• W2134913151 cites W2073187473 @default.
• W2134913151 cites W2073449985 @default.
• W2134913151 cites W2076795776 @default.
• W2134913151 cites W2077455609 @default.
• W2134913151 cites W2078621823 @default.
• W2134913151 cites W2083063954 @default.
• W2134913151 cites W2084888020 @default.
• W2134913151 cites W2084911166 @default.
• W2134913151 cites W2088891222 @default.
• W2134913151 cites W2089289079 @default.
• W2134913151 cites W2092926551 @default.
• W2134913151 cites W2093271285 @default.
• W2134913151 cites W2095403170 @default.
• W2134913151 cites W2096882342 @default.
• W2134913151 cites W2097863680 @default.
• W2134913151 cites W2105047187 @default.
• W2134913151 cites W2107135308 @default.
• W2134913151 cites W2129928127 @default.
• W2134913151 cites W2135609089 @default.
• W2134913151 cites W2158527339 @default.
• W2134913151 cites W2159102561 @default.
• W2134913151 cites W2165016189 @default.
• W2134913151 cites W2166496419 @default.
• W2134913151 cites W2168450515 @default.
• W2134913151 doi "https://doi.org/10.1016/j.expneurol.2014.04.011" @default.
• W2134913151 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24747357" @default.
• W2134913151 hasPublicationYear "2014" @default.
• W2134913151 type Work @default.
• W2134913151 sameAs 2134913151 @default.
• W2134913151 citedByCount "50" @default.
• W2134913151 countsByYear W21349131512014 @default.
• W2134913151 countsByYear W21349131512015 @default.
• W2134913151 countsByYear W21349131512016 @default.
• W2134913151 countsByYear W21349131512017 @default.
• W2134913151 countsByYear W21349131512018 @default.
• W2134913151 countsByYear W21349131512019 @default.
• W2134913151 countsByYear W21349131512020 @default.
• W2134913151 countsByYear W21349131512021 @default.
• W2134913151 countsByYear W21349131512022 @default.
• W2134913151 countsByYear W21349131512023 @default.
• W2134913151 crossrefType "journal-article" @default.
• W2134913151 hasAuthorship W2134913151A5011110065 @default.
• W2134913151 hasAuthorship W2134913151A5030271784 @default.
• W2134913151 hasAuthorship W2134913151A5034813656 @default.
• W2134913151 hasAuthorship W2134913151A5047762447 @default.
• W2134913151 hasAuthorship W2134913151A5082558832 @default.
• W2134913151 hasBestOaLocation W21349131512 @default.
• W2134913151 hasConcept C126322002 @default.
• W2134913151 hasConcept C137183658 @default.
• W2134913151 hasConcept C142724271 @default.

• next